Metagen Therapeutics

Biotechnology company focusing on drug discovery and development based on intestinal microbiome-based therapeutics

Biotechnology
Genomics
Synthetic Biology
Healthcare & Life Sciences

2

Rounds

1

Industry

3

Tags

Sep 25, 2026

Latest raise

Funding activity · 2 rounds

Raise timeline

Sep 25, 2026
JPY 1.9M
Series B
Led by GLIN Impact Capital
- GLIN Impact Capital
Article coming soon.
Sep 4, 2026
JPY 200M
Series B
- Hokkaido University Green Frontier Fund No.1
- Tokai Research and Development No.1
Metagen Therapeutics Raises ¥200M Series B for Microbiome-Based Drug Discovery
Metagen Therapeutics Secures ¥200M Series B Metagen Therapeutics, a biotechnology company focused on drug discovery and development based on intestinal microbi…
Read article

Pricing

Research Metagen Therapeutics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

Access to core AI adoption signals
3–5 curated slices per week
30–60 companies / week
AI Adoption Score
Deal-ready insights (why + pitch angle)
Basic filters (recency, slice, score)
CSV export

Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

Everything in Growth, plus:
Full access to all slices
60–120 companies / week
Higher-frequency signal updates
Priority / early signals (before Growth)
Advanced filters (industry, size, use case)
Deeper company insights
Faster export + bulk workflows

Act on this raise

See if Metagen Therapeutics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

Start free All funding Visit website

© 2026 VeilStrat. All rights reserved.All systems operational